Remove Doctor Remove Hormones Remove Research
article thumbnail

Doctor Reveals What Happens When You Stop Taking Ozempic

AuroBlog - Aurous Healthcare Clinical Trials blog

Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger. Drugs like Ozempic are very effective at helping most people who take them lose weight. But does weight come back when you stop using […]

Doctor 154
article thumbnail

Hormone Therapy for Prostate Cancer May Raise Heart Risks

The Pharma Data

20, 2020 — Hormone therapy can be a lifesaver for men with prostate cancer , but it also appears to put some at increased risk of heart problems, a new study reports. “Our data are not suggesting that androgen deprivation therapy definitely causes worse heart health,” said lead researcher Dr. . FRIDAY, Nov.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prostate Cancer Awareness Month 2024: New Research and Screening Horizons

XTalks

Oral ADT Treatment: A New Option for Hormone-Sensitive Prostate Cancer In August 2024, the National Institute for Health and Care Excellence (NICE) recommended Orgovyx (relugolix) as the first oral androgen deprivation therapy (ADT) for men with hormone-sensitive prostate cancer in England.

article thumbnail

A treatment for a deadly condition in newborns fails to improve outcomes, study finds

STAT News

For babies born with hypoxic-ischemic encephalopathy, commonly called birth asphyxia, doctors have limited options. A new study , published Wednesday in the New England Journal of Medicine, found that the hormone erythropoietin did not improve survival and other outcomes in newborns with hypoxic-ischemic encephalopathy.

article thumbnail

Explore the Future of Cancer Detection and Women’s Health with UBC Researchers!

Trialfacts

Join researchers as they reshape the landscape of cancer prevention and make a lasting impact on women’s health, today! Participants will be helping to advance prevention research on uterine cancer. Your Rights Who Can Participate? Why Participate? Participants may receive an early diagnosis of an underlying pathology.

article thumbnail

IBD And Your Menstrual Cycle: Why More Research Is Needed

Find Me Cure

From the way they metabolize drugs to diseases and conditions that mostly affect women (like migraines) and so remain under-researched, there is a medical bias that unfairly affects half the population. Some doctors caution that women in remission can sporadically take NSAIDs to manage painful periods but others warn against these drugs.

article thumbnail

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

The Pharma Data

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer.